Zach McLellan, Tara Hansen, Tom Tyler, and David Dahan discuss notable presentations and data releases from the 2020 ESMO meeting.
Topics covered in this episode include:
• LEAP-005: Lenvima + Keytruda in solid tumors (1:25)
• Phase III IPATential150 data: ipatasertib in mCRPC (5:59)
• Phase III - JAVELIN HEAD AND NECK 100: Bavencio (12:12)
• Phase III - IMpassion131 and IMpassion130: Tecentriq in TNBC (17:40)
• Phase III - CheckMate 649: Opdivo in gastric cancer + oesophageal cancer (22:52)
• Phase III - CROWN trial: Lorbrena vs. Xalkori in NSCLC (30:20)
To learn more about Datamonitor Healthcare, Biomedtracker, and other offerings from Pharma Intelligence, visit:
pharmaintelligence.informa.com/
